Brent Saunders

Brent Saunders has over 25 years of experience in leadership roles at several prominent global pharmaceutical and healthcare companies. He currently serves as CEO, President and Chairman of Vesper Healthcare. Previously, he served as Chairman, President and Chief Executive Officer of Allergan until its acquisition by AbbVie in May 2020. Prior to this, Brent served as Chief Executive Officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis in 2014. Following the merger with Actavis, Brent was named Chief Executive Officer of the combined business and in 2015, he led Actavis’ acquisition by Allergan. From March 2010 until August 2013, Brent served as Chief Executive Officer of Bausch + Lomb Incorporated (NYSE: BHC), a leading global eye health company, until its acquisition by Valeant in 2013. Mr. Saunders holds a B.A. degree from the University of Pittsburgh, a J.D. degree from the Temple University School of Law, and an MBA from the Temple University School of Business.